Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 88
Filter
Add more filters










Publication year range
1.
Ann Pharm Fr ; 80(5): 711-717, 2022 Sep.
Article in French | MEDLINE | ID: mdl-35101367

ABSTRACT

OBJECTIVES: Evaluate the interest in the MyDéfi application as a tool to help pharmacists identify and manage excessive alcohol consumption, as well as their perception and knowledge of alcohol and their possible role in its management. METHODS: Prospective mixed qualitative and quantitative study, based on face-to-face semi-directive interviews. RESULTS: The 101 pharmacists interviewed in Hauts-de-France region considered that the detection of alcohol consumption was part of their mission, even if it is a difficult subject, and that they had received specific training in alcohology during their university training. Only 12% were aware of early screening and brief intervention on alcohol. Several obstacles were mentioned, such as the lack of training and confidentiality, and difficulties related to patient specificities. Forty-one percent said that the pharmacy was not suitable and almost 72% said that the MyDéfi application could be useful for screening and 91% would recommend the application as one of the best supports, easy to advise with a personalised follow-up. For 32%, the application is accessible to patients (40% think that the main drawback of the application is inaccessibility and 27% its cost). CONCLUSION: Pharmacists consider that excessive alcohol use is a major problem that should mobilise them but many do not feel ready to offer brief interventions. After seeing how the MyDéfi application worked, the majority considered that it could help them in their prevention mission.


Subject(s)
Mobile Applications , Pharmacists , Alcohol Drinking/prevention & control , Ethanol , Humans , Prospective Studies , Smartphone
2.
J Clin Pharm Ther ; 39(1): 45-52, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24106917

ABSTRACT

WHAT IS KNOWN AND OBJECTIVE: Patients' poor adherence to medications is reported to be related to the individual patients' beliefs and cognitions and their trust of the medical staff. However, the causes of the two forms of non-adherence, intentional and unintentional behaviours, have yet to be clarified. This study compared psychological latent factors associated with intentional and unintentional non-adherence to chronic medication regimens, focusing on the potential effects of (i) patients' dissatisfaction with treatment and their relationships with the medical staff and (ii) patients' subliminal rational thinking processes, which weighed the positive values such as their expectations of benefits from treatment against negative values such as their dissatisfaction. METHODS: Two cross-sectional surveys were undertaken of patients given medications for chronic diseases, using a questionnaire developed and validated in this study. One survey was undertaken in three hospitals and the other survey, online throughout Japan. We scored the individual latent factors using the questionnaire and calculated the differential score between two negatively correlated latent factors to quantify patients' subliminal rational thinking process. We compared the adjusted odds ratio (OR) of latent factors between intentional and unintentional non-adherence to medication in both surveys. RESULTS AND DISCUSSION: Of the eligible subjects, 149 hospitalized patients and 524 survey participants completed the questionnaire. Intentional non-adherence was associated with patient dissatisfaction with treatment including interpersonal relationships with medical staff in both hospitalized patients and online survey participants (95% confidence interval of adjusted OR for Dissatisfaction, 1·20-16·26 in the hospital-based survey and 1·33-3·45 in the online survey). In both surveys, intentional non-adherence was significantly associated with the differential score between two negatively correlated latent factors, Willingness and Dissatisfaction (P = 0·02 in the hospital-based survey and P < 0·001 in the online survey). However, these associations were not evident in unintentionally non-adherent patients. WHAT IS NEW AND CONCLUSIONS: Patients' dissatisfaction and their resulting rational judgments are unique, consistent determinants of intentional non-adherence to medications, but not of unintentional non-adherence.


Subject(s)
Judgment , Medication Adherence , Patient Satisfaction , Adult , Aged , Chronic Disease/drug therapy , Cross-Sectional Studies , Female , Humans , Japan , Male , Middle Aged , Professional-Patient Relations , Surveys and Questionnaires
3.
Neuroscience ; 161(2): 427-40, 2009 Jun 30.
Article in English | MEDLINE | ID: mdl-19348874

ABSTRACT

An important factor that may influence addiction liability is exposure during the early life period. Exposure to ethanol, early in life, can have long-lasting implications on brain function and drugs of abuse response later in life. In the present study we investigated the behavioral responses to ethanol and to psychostimulants in Long Evans rats that have been exposed to pre- and postnatal ethanol. Since a relationship between heightened drug intake and susceptibility to drug-induced locomotor activity/sensitization has been demonstrated, we tested these behavioral responses, in control and early life ethanol-exposed animals. The young adult male and female progeny were tested for locomotor response to alcohol, cocaine and d-amphetamine. Sedative, rewarding effects of alcohol and alcohol consumption were measured. Our results show that early life ethanol exposure behaviorally sensitized animals to subsequent ethanol and psychostimulants exposure. Ethanol-exposed animals were also more sensitive to the hyperlocomotor effects of all drugs of abuse tested and to those of the dopamine receptor agonist apomorphine. Locomotor sensitization to repeated injections of cocaine was facilitated in ethanol-exposed animals. Ethanol-induced conditioned place preference was also facilitated in ethanol-exposed animals. Ethanol consumption and preference were increased after early life ethanol exposure and this was associated with decreased sensitivity to the sedative effects of ethanol. The altered behavioral responses to drugs of abuse were associated with decreased striatal dopamine transporter and hippocampal NMDAR binding. Our results outline an increased vulnerability to rewarding and stimulant effects of ethanol and psychostimulants and support the epidemiological and clinical data that suggested that early chronic exposure to ethanol may increase the propensity for later self-administration of ethanol or other substances.


Subject(s)
Central Nervous System Depressants/pharmacology , Central Nervous System Stimulants/pharmacology , Ethanol/pharmacology , Maternal Exposure , Maternal-Fetal Exchange , Prenatal Exposure Delayed Effects/physiopathology , Animals , Animals, Newborn , Body Weight/drug effects , Conditioning, Psychological/drug effects , Corpus Striatum/metabolism , Dopamine Plasma Membrane Transport Proteins/metabolism , Drug Synergism , Female , Hippocampus/metabolism , Litter Size/drug effects , Male , Motor Activity/drug effects , Pregnancy , Protein Binding , Radioligand Assay , Rats , Rats, Long-Evans , Receptors, N-Methyl-D-Aspartate/metabolism , Reflex, Abnormal
4.
J Clin Pharm Ther ; 34(6): 719-22, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20175806

ABSTRACT

BACKGROUND AND OBJECTIVE: Pertussis developed in Kagawa University Medical School and University Hospital in May 2007. To control the outbreak and prevent the infection of hospital inpatients, the Infection Control Team (ICT) carried out the prophylactic administration of erythromycin (EM) to hospital staff (1566 staff) who might be exposed to Bordetella pertussis. METHODS: An oral dose of 1000 mg/day EM was given for 10 days. To assess compliance and estimate the frequency of adverse effect, the ICT conducted a questionnaire survey. RESULTS AND DISCUSSION: Of 942 respondents (response rate: 60.2%), 264 (28.0%) experienced some form of EM adverse effects, of which the most commonly reported involved digestive organ symptoms, e.g. diarrhoea (15.6%), stomachache (7.5%), nausea (3.6%), epigastric distress (2.1%) and abdominal distention (1.8%). More importantly, 246 participants (26.1%) stopped taking the EM before completing 10 days because of perceived adverse effects. CONCLUSION: These results indicate that EM appears to cause adverse effects more frequently than reported in the package insert in Japan. The prophylactic use of EM for pertussis infection is recognized in the guideline of the Centers for Disease Control and Prevention. However, this study suggests that attention should be paid to EM non-compliance during a pertussis outbreak, which could extend the duration of the outbreak and increase the number of affected patients.


Subject(s)
Anti-Bacterial Agents/adverse effects , Cross Infection/prevention & control , Disease Outbreaks , Erythromycin/adverse effects , Whooping Cough/epidemiology , Humans
5.
Genes Brain Behav ; 7(8): 887-98, 2008 Nov.
Article in English | MEDLINE | ID: mdl-19097273

ABSTRACT

We have shown previously that mice lacking the adenosine A2A receptor (A2AR) generated on a CD1 background self-administer more ethanol and exhibit hyposensitivity to acute ethanol. We aimed to investigate if the increased propensity of A2A(-/-) mice to consume ethanol is associated with an altered sensitivity in the motivational properties of ethanol in the conditioned place preference (CPP) and conditioned taste aversion (CTA) paradigms and with an altered development of sensitization to the locomotor effects of ethanol. We also tested their sensitivity to the anxiolytic effects of ethanol. Our results show that A2A(-/-) mice produced on a CD1 background displayed a reduced ethanol-induced CPP and an increased sensitivity to the anxiolytic and locomotorstimulant effects of ethanol, but they did not show alteration in ethanol-induced CTA and locomotor sensitization. Ethanol-induced CPP, ethanol consumption and the locomotor effects of ethanol were also tested in A2A(-/-) mice produced on a C57BL/6J background. Our results emphasized the importance of the genetic background because alteration in ethanol consumption and preference, ethanol-induced CPP and locomotor-stimulant effects were not found in knockout mice produced on the alcohol-preferring C57BL/6J genetic background. Finally, the A2AR agonist, 2-p-(2-carboxyethyl)-phenylethylamino-50-N-ethylcarboxamidoadenosine hydrochloride (CGS 21680), reduced ethanol consumption and preference in C57BL/6J mice. In conclusion, A2AR deficiency in mice generated on a CD1 background leads to high ethanol consumption that is associated with an increased sensitivity to the locomotor-stimulant/anxiolytic effects of ethanol and a decrease in ethanol-induced CPP.


Subject(s)
Adenosine/metabolism , Alcohol-Induced Disorders, Nervous System/genetics , Brain/drug effects , Ethanol/pharmacology , Receptor, Adenosine A2A/drug effects , Alcohol-Induced Disorders, Nervous System/metabolism , Alcohol-Induced Disorders, Nervous System/physiopathology , Animals , Anti-Anxiety Agents/pharmacology , Anxiety/drug therapy , Anxiety/genetics , Anxiety/metabolism , Behavior, Animal/drug effects , Behavior, Animal/physiology , Brain/metabolism , Brain/physiopathology , Central Nervous System Depressants/pharmacology , Conditioning, Psychological/drug effects , Conditioning, Psychological/physiology , Disease Models, Animal , Drug Resistance/drug effects , Drug Resistance/genetics , Genotype , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Motivation , Motor Activity/drug effects , Motor Activity/physiology , Receptor, Adenosine A2A/metabolism , Species Specificity
6.
Alcohol Clin Exp Res ; 32(4): 567-72, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18341651

ABSTRACT

BACKGROUND: The D1 dopamine receptor has been involved in a number of brain functions, including motor control, inattentive symptoms and reward and reinforcement mechanisms. Indeed, DRD1 antagonists may reduce cocaine-seeking behavior and the acquisition of cocaine-cue associations. The D1.1/r4532 marker of the DRD1 gene has been associated with a large set of phenotypes including addictive behaviors, but none with alcohol dependence per se. METHODS: We analyzed a population of 134 patients with alcohol dependence, also assessing more homogeneous (severe) phenotypes, comparing this sample with a healthy control population, assessing two SNPs within the DRD1 gene in order to depict the role of DRD1 polymorphisms and haplotypes. RESULTS: The T allele of the rs686 polymorphism within DRD1 gene was significantly more frequent in patients with alcohol dependence (p = 0.0008), with a larger excess for patients with severe dependence (p = 6 x 10(-6)), and even more for patients with severe complications such as withdrawal seizures (p = 7 x 10(-7)). A specific haplotype rs686*T-rs4532*G within the DRD1 gene was significantly more precisely associated with alcohol dependence in our sample (p = 5 x 10(-6)). CONCLUSIONS: Even though chance finding cannot be ruled out, convergent evidence is given that the DRD1 gene is a susceptibility gene in alcohol dependence, regarding the fact that relying on more homogeneous phenotypes (i.e., more severe patients) and more informative genetic markers (i.e., haplotypes) reinforce the initial association.


Subject(s)
Alcoholism/genetics , Genetic Linkage/genetics , Haplotypes/genetics , Receptors, Dopamine D1/genetics , Adult , Aged , Female , Genetic Markers/genetics , Humans , Male , Middle Aged , Polymorphism, Genetic/genetics
7.
J Physiol ; 586(5): 1413-27, 2008 Mar 01.
Article in English | MEDLINE | ID: mdl-18096598

ABSTRACT

Acute ethanol depresses respiration, but little is known about chronic ethanol exposure during gestation and breathing, while the deleterious effects of ethanol on CNS development have been clearly described. In a recent study we demonstrated that pre- and postnatal ethanol exposure induced low minute ventilation in juvenile rats. The present study analysed in juvenile rats the respiratory response to hypoxia in vivo by plethysmography and the phrenic (Phr) nerve response to ischaemia in situ. Glycinergic neurotransmission was assessed in situ with strychnine application and [(3)H]strychnine binding experiments performed in the medulla. After chronic ethanol exposure, hyperventilation during hypoxia was blunted in vivo. In situ Phr nerve response to ischaemia was also impaired, while gasping activity occurred earlier and recovery was delayed. Strychnine applications in situ (0.05-0.5 microM) demonstrated a higher sensitivity of expiratory duration in ethanol-exposed animals compared to control animals. Moreover, [(3)H]strychnine binding density was increased after ethanol and was associated with higher affinity. Furthermore, 0.2 microM strychnine in ethanol-exposed animals restored the low basal Phr nerve frequency, but also the Phr nerve response to ischaemia and the time to recovery, while gasping activity appeared even earlier with a higher frequency. Polycythaemia was present after ethanol exposure whereas lung and heart weights were not altered. We conclude that chronic ethanol exposure during rat brain development (i) induced polycythaemia to compensate for low minute ventilation at rest; (ii) impaired the respiratory network adaptive response to low oxygen because of an increase in central glycinergic tonic inhibitions, and (iii) did not affect gasping mechanisms. We suggest that ethanol exposure during early life can be a risk factor for the newborn respiratory adaptive mechanisms to a low oxygen environment.


Subject(s)
Animals, Newborn/physiology , Central Nervous System Depressants/pharmacology , Ethanol/pharmacology , Oxygen/metabolism , Prenatal Exposure Delayed Effects/physiopathology , Respiratory Mechanics/drug effects , Respiratory Mechanics/physiology , Animals , Central Nervous System Depressants/adverse effects , Disease Models, Animal , Dose-Response Relationship, Drug , Ethanol/adverse effects , Female , Male , Poisons/pharmacology , Polycythemia/physiopathology , Potassium/metabolism , Pregnancy , Prenatal Exposure Delayed Effects/chemically induced , Rats , Rats, Sprague-Dawley , Strychnine/pharmacology
8.
Article in English | MEDLINE | ID: mdl-17282211

ABSTRACT

We tested the effects of some kinds of time-varying magnetic fields (0-1.2T) on neurotransmitter-induced transient increases in intracellular Ca2+concentration ([Ca2+]) of cultured chromaffin and HeLa cells. After these cells were exposed for 2 hours to these magnetic fields, transient increases in [Ca2+]i by addition of acetylcholine or histamine were measured. In control cells, after addition of these neurotransmitters [Ca2+]i was increased immediately and then decreased with time in both cells. But, addition of these drugs to the magnetic fields exposed cells increased [Ca2+]i to a level similar to that for control cells. These results suggest that the transient increases in [Ca2+]i were not significantly influenced by the magnetic fields used in this experiment.

9.
Eur J Pharmacol ; 430(2-3): 359-67, 2001 Nov 02.
Article in English | MEDLINE | ID: mdl-11711055

ABSTRACT

Hypertension often complicates type 2 diabetes mellitus, and angiotensin converting enzyme inhibitor treatment has been shown to improve insulin resistance in such cases. However, the effect of angiotensin II type-1 (AT(1)) receptor antagonists on insulin resistance is still controversial. To gain further information on this effect, we examined the effect of losartan on insulin resistance in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of type 2 diabetes mellitus. Losartan administration alone lowered systolic blood pressure, but did not improve oral glucose tolerance test or insulin resistance in OLETF rats. However, the administration of losartan with exercise significantly improved both systolic blood pressure and insulin resistance relative to control OLETF rats. On the other hand, losartan treatment, regardless of exercise, increased glucose uptake in excised soleus muscle and fat cells. To explore the beneficial effect of losartan on skeletal muscle glucose uptake, we examined intracellular signaling of soleus muscle. Although Akt activity and glucose transporter type 4 (GLUT4) expressions were not affected by losartan with or without exercise, extracellular signal-regulated kinase (ERK1/2) and p38 mitogen-activated protein (MAP) kinase activities were increased by both interventions. These results indicate that angiotensin AT(1) receptor antagonist improved local insulin resistance, but not systemic insulin resistance. These findings may explain the controversy over the effect of angiotensin AT(1) receptor antagonists on insulin resistance in clinical use. The enhancing effect of angiotensin AT(1) receptor antagonist on skeletal muscle glucose uptake may be attributable to MAP kinase activation or other mechanisms rather than phosphatidylinositol 3-kinase activation.


Subject(s)
Antihypertensive Agents/pharmacology , Insulin Resistance , Losartan/pharmacology , Muscle Proteins , Physical Conditioning, Animal/physiology , Protein Serine-Threonine Kinases , Adipocytes/drug effects , Adipocytes/metabolism , Animals , Blood Glucose/drug effects , Blood Glucose/metabolism , Blood Pressure/drug effects , Blotting, Western , Body Weight/drug effects , Deoxyglucose/pharmacokinetics , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/physiopathology , Enzyme Activation/drug effects , Glucose/pharmacokinetics , Glucose/pharmacology , Glucose Tolerance Test , Glucose Transporter Type 4 , Heart Rate/drug effects , Insulin/blood , JNK Mitogen-Activated Protein Kinases , Male , Mitogen-Activated Protein Kinase 1/drug effects , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/drug effects , Mitogen-Activated Protein Kinases/metabolism , Monosaccharide Transport Proteins/drug effects , Monosaccharide Transport Proteins/metabolism , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Phosphorylation/drug effects , Proto-Oncogene Proteins/drug effects , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-akt , Rats , Rats, Inbred OLETF , p38 Mitogen-Activated Protein Kinases
10.
Life Sci ; 69(15): 1709-15, 2001 Aug 31.
Article in English | MEDLINE | ID: mdl-11665832

ABSTRACT

The relaxation effect of cilostazol, a phosphodiesterase III inhibitor, on the thoracic aorta was investigated. Cilostazol induced the relaxation of the thoracic aorta precontracted by phenylephrine in a concentration-dependent manner. The concentration-dependent relaxation was shifted to the right in the endothelium denuded aorta compared with that of intact endothelium, suggesting that this relaxation was partly dependent on endothelium. Cilostazol-induced relaxation of thoracic aorta tone was reversed by treatment with N(G)-nitro L-arginine (L-NNA), a competitive inhibitor of nitric oxide (NO) synthase. Cilostazol also significantly increased the NO level in the porcine thoracic aorta. In rats treated with cilostazol, the urinary excretion of nitrites, a stable metabolite of NO, and basal production of NO of the aortic ring were significantly greater than in those without treatment. These findings indicate that cilostazol-induced vasodilation of the rat thoracic aorta was dependent on the endothelium, which released NO from aortic endothelial cells.


Subject(s)
3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors , Endothelium, Vascular/physiology , Phosphodiesterase Inhibitors/pharmacology , Tetrazoles/pharmacology , Vasodilation/drug effects , Vasodilator Agents/pharmacology , Animals , Aorta, Thoracic/drug effects , Aorta, Thoracic/physiology , Cilostazol , Culture Techniques , Cyclic Nucleotide Phosphodiesterases, Type 3 , Dose-Response Relationship, Drug , Male , Nitric Oxide/biosynthesis , Nitrites/urine , Rats , Rats, Inbred OLETF , Rats, Sprague-Dawley
11.
Auris Nasus Larynx ; 28(3): 215-8, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11489363

ABSTRACT

OBJECTIVE: This study investigated the vasoactive effect of tranexamic acid on the cochlear blood flow in guinea pigs. METHOD: 3 ml solution (infusion speed, 0.5 ml/min) containing different concentrations of tranexamic acid was intravenously infused into 15 guinea pigs under general anesthesia. The guinea pigs were grouped according to four levels of dosage of the medicine (470 mg/kg, n=6; 220 mg/kg, n=3; 4 mg/kg, n=3; 1 mg/kg, n=3). Before administering medicine, saline solution was administered in similar volume and speed as a control. The cochleas were surgically exposed and laser Doppler flowmetry monitored cochlear blood flow volume (CBF). The left femoral artery was cannulated to permit a transducer to monitor systemic blood pressure (BP). RESULTS: (1) Stimulatory effect of tranexamic acid on CBF was dose-dependent at concentrations of 1-470 mg/kg and, (2) the time course of changes in CBF was almost identical to that in BP following tranexamic acid administration. CONCLUSION: Preliminary findings suggest that intravenous administration of tranexamic acid increases CBF due to vasomotorial mechanism effect on BP.


Subject(s)
Cochlea/blood supply , Cochlea/drug effects , Laser-Doppler Flowmetry/methods , Tranexamic Acid/pharmacology , Vasodilator Agents/pharmacology , Animals , Blood Pressure/drug effects , Dose-Response Relationship, Drug , Guinea Pigs , Infusions, Intravenous , Male , Tranexamic Acid/administration & dosage , Vasodilator Agents/administration & dosage
12.
Chem Pharm Bull (Tokyo) ; 49(5): 576-80, 2001 May.
Article in English | MEDLINE | ID: mdl-11383609

ABSTRACT

The free radical scavenging and/or generating activity of dopamine-4-O-sulfate was examined and compared with that of dopamine. In humans, dopamine mostly exists in two isomeric forms of sulfate ester conjugates as metabolites; i.e., dopamine-3-O-sulfate and dopamine-4-O-sulfate in the circulation. Dopamine is generally believed to be oxidized by molecular oxygen or another reactive oxygen species under physiological conditions, to form oxidized dopamine derivatives that are cytotoxic. However, it is not known whether dopamine conjugates are generated on interaction with reactive oxygen species or not. In the present study, we measured the susceptibility to oxidization of dopamine-4-O-sulfate by using electron paramagnetic resonance (EPR) spectroscopy and optical absorption spectrometry. Dopamine was easily oxidized and dopamine-derived radicals appeared, whereas dopamine-4-O-sulfate was not oxidized under physiological conditions. Furthermore, dopamine-4-O-sulfate did not react with a strong oxidizing agent, sodium periodate. These results suggest that dopamine-4-O-sulfate has resistance against autoxidation, and seems to be a stable metabolite of dopamine.


Subject(s)
Dopamine/pharmacology , Free Radical Scavengers/pharmacology , Dopamine/analogs & derivatives , Dopamine/chemistry , Dopamine/radiation effects , Electron Spin Resonance Spectroscopy , Free Radical Scavengers/chemistry , Free Radicals/chemistry , Horseradish Peroxidase/chemistry , Hydroxyl Radical/chemistry , Periodic Acid/chemistry , Spectrophotometry, Ultraviolet , Superoxides/chemistry , Ultraviolet Rays , Xanthine Oxidase/metabolism
13.
Jpn J Pharmacol ; 84(2): 146-55, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11128037

ABSTRACT

It was previously found that human chymase cleaves big endothelins (ETs) at the Tyr31-Gly32 bond and produces 31-amino acid ETs (1-31). In the present study, human plasma concentrations of ET-1 (1-31) and ET-1 were examined and the effect of synthetic ET-1 (1-31) on the proliferation of cultured human mesangial cells (HMCs) was investigated. The proliferative effect of ET-1 (1-31) was evaluated from the [3H]-thymidine uptake. The activity of extracellular signal-regulated kinase (ERK) and DNA binding activity of activator protein-1 were determined by using an in-gel kinase assay and gel mobility shift assay, respectively. Immunoreactive ET-1 (1-31) was detectable in plasma, but the level was slightly lower than that of ET-1. ET-1 (1-31) increased [3H]-thymidine incorporation in HMCs to a degree similar to that induced by ET-1. ET-1 (1-31) also activated ERK1/2. Inhibition of protein kinase C and ERK kinase caused a reduction of ET-1 (1-31)-induced ERK1/2 activation. The ERK1/2 activation was followed by an increase in transcription factor activator protein-1 DNA binding activity. These findings suggest that ET-1 (1-31) is a bioactive peptide in humans and ET-1 (1-31) itself stimulates HMC proliferation.


Subject(s)
Endothelins/pharmacology , Glomerular Mesangium/drug effects , MAP Kinase Kinase Kinase 1 , Peptide Fragments/pharmacology , Adult , Cell Division/drug effects , Cells, Cultured , DNA/drug effects , DNA/metabolism , Dose-Response Relationship, Drug , Drug Interactions , Endothelin Receptor Antagonists , Endothelin-1/pharmacology , Endothelins/blood , Endothelins/pharmacokinetics , Enzyme Activation , Enzyme Inhibitors/pharmacology , Female , Glomerular Mesangium/cytology , Glomerular Mesangium/metabolism , Glycopeptides/pharmacology , Humans , Male , Mitogen-Activated Protein Kinases/metabolism , Peptide Fragments/blood , Peptide Fragments/pharmacokinetics , Protein Kinase C/antagonists & inhibitors , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/antagonists & inhibitors , Transcription Factor AP-1/metabolism
14.
J Biol Chem ; 275(3): 1551-6, 2000 Jan 21.
Article in English | MEDLINE | ID: mdl-10636843

ABSTRACT

The objective of this study was to elucidate the origin of the nitric oxide-forming reactions from nitrite in the presence of the iron-N-methyl-D-glucamine dithiocarbamate complex ((MGD)(2)Fe(2+)). The (MGD)(2)Fe(2+) complex is commonly used in electron paramagnetic resonance (EPR) spectroscopic detection of NO both in vivo and in vitro. Although it is widely believed that only NO can react with (MGD)(2)Fe(2+) complex to form the (MGD)(2)Fe(2+).NO complex, a recent article reported that the (MGD)(2)Fe(2+) complex can react not only with NO, but also with nitrite to produce the characteristic triplet EPR signal of (MGD)(2)Fe(2+).NO (Hiramoto, K., Tomiyama, S., and Kikugawa, K. (1997) Free Radical Res. 27, 505-509). However, no detailed reaction mechanisms were given. Alternatively, nitrite is considered to be a spontaneous NO donor, especially at acidic pH values (Samouilov, A., Kuppusamy, P., and Zweier, J. L. (1998) Arch Biochem. Biophys. 357, 1-7). However, its production of nitric oxide at physiological pH is unclear. In this report, we demonstrate that the (MGD)(2)Fe(2+) complex and nitrite reacted to form NO as follows: 1) (MGD)(2)Fe(2).NO complex was produced at pH 7.4; 2) concomitantly, the (MGD)(3)Fe(3+) complex, which is the oxidized form of (MGD)(2)Fe(2+), was formed; 3) the rate of formation of the (MGD)(2)Fe(2+).NO complex was a function of the concentration of [Fe(2+)](2), [MGD], [H(+)] and [nitrite].


Subject(s)
Ferrous Compounds/metabolism , Nitric Oxide/chemical synthesis , Nitrites/metabolism , Sorbitol/analogs & derivatives , Thiocarbamates/metabolism , Dose-Response Relationship, Drug , Electron Spin Resonance Spectroscopy , Hydrogen/metabolism , Hydrogen-Ion Concentration , Iron/metabolism , Kinetics , Sorbitol/metabolism , Spin Labels , Time Factors
15.
Life Sci ; 68(6): 635-45, 2000 Dec 29.
Article in English | MEDLINE | ID: mdl-11205878

ABSTRACT

It was reported that human chymase cleaves big endothelins (ETs) at the Tyr31-Gly32 bond and produces 31-amino acid ETs(1-31). In this study, we investigated the effect of ET-1(1-31) on p38 mitogen-activated protein kinase (p38-MAPK) activity in human mesangial cells (HMCs). By measuring the kinase activity, we demonstrated that ET-1 (1-31) activated the p38-MAPK dose-dependently (10(-9) M to 10(-7) M), which was inhibited by SB203580. The p38-MAPK activation induced by ET-1(1-31) peaked at 10 minutes. BQ123 almost abolished ET-1(1-31)-induced p38-MAPK activation, whereas BQ788 failed to inhibit it. These findings suggest that the stimulatory effect of ET-1(1-31) on p38-MAPK activation is mediated through ET(A) or ET(A)-like receptor. In conclusion, ET-1(1-31) induced increase in p38-MAPK activation in cultured HMCs.


Subject(s)
Glomerular Mesangium/enzymology , Blotting, Western , Cells, Cultured , Glomerular Mesangium/drug effects , Humans , Imidazoles/pharmacology , Phosphorylation , Pyridines/pharmacology , Stimulation, Chemical
16.
J Cardiovasc Pharmacol ; 36 Suppl 2: S15-8, 2000.
Article in English | MEDLINE | ID: mdl-11206714

ABSTRACT

The long-term effects of ouabain, an inhibitor of Na+/K+ -ATPase, on catecholamine formation in cultured bovine adrenal chromaffin cells were examined. The increase in [14C]catecholamine formation from [14C]tyrosine induced by ouabain was dependent on incubation time, and its maximal effect was observed after incubation for 8 h. The stimulatory effect of ouabain was concentration dependent (10-300 nM), causing maximal stimulation at 300 nM. The formation of [14C]catecholamines induced by ouabain was not increased by incubation with [14C]DOPA instead of [14C]tyrosine. Ouabain-induced [14C]catecholamine formation was influenced by decreases in extracellular Ca2+ concentration, but not by the presence of cycloheximide or actinomycin D. These results suggested that ouabain stimulates continuous activation of hydroxylation of tyrosine through a Ca2+ -dependent mechanism in cultured bovine adrenal chromaffin cells.


Subject(s)
Catecholamines/biosynthesis , Chromaffin Cells/drug effects , Enzyme Inhibitors/pharmacology , Ouabain/pharmacology , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Animals , Calcium/metabolism , Cattle , Cells, Cultured , Chromaffin Cells/metabolism , Tyrosine/metabolism , Tyrosine 3-Monooxygenase/physiology
17.
Life Sci ; 65(22): PL267-72, 1999.
Article in English | MEDLINE | ID: mdl-10597897

ABSTRACT

We found that human chymase selectively produces 31-amino-acid length endothelins (1-31) (ETs(1-31)). We investigated the effect of synthetic ET-1(1-31) on intracellular free Ca2+ concentration ([Ca2+]i) in cultured human mesangial cells. ET-1(1-31) increased [Ca2+]i in a concentration-dependent manner to a similar extent as ET-1. The ET-1 (1-31)-induced [Ca2+]i increase was not influenced by removal of extracellular Ca2+ but was inhibited by thapsigargin. ET-1(1-31)-induced [Ca2+]i increase was not affected by phosphoramidon. It was inhibited by BQ123, but not by BQ788. These results suggest that ET-1(1-31) by itself exhibits bioactive properties probably through endothelin ET(A) or ET(A)-like receptors. Since human chymase has been reported to exist in the kidney, ET-1(1-31) may be a candidate substance for mesangium-relevant diseases.


Subject(s)
Calcium/metabolism , Endothelins/pharmacology , Glomerular Mesangium/metabolism , Intracellular Fluid/metabolism , Peptide Fragments/pharmacology , Aspartic Acid Endopeptidases/antagonists & inhibitors , Aspartic Acid Endopeptidases/metabolism , Calcium/antagonists & inhibitors , Cells, Cultured , Chymases , Dose-Response Relationship, Drug , Endothelin-1/pharmacology , Endothelin-Converting Enzymes , Glomerular Mesangium/drug effects , Glomerular Mesangium/enzymology , Glycopeptides/pharmacology , Humans , Intracellular Fluid/drug effects , Metalloendopeptidases , Microscopy, Confocal , Peptides, Cyclic/pharmacology , Protease Inhibitors/pharmacology , Serine Endopeptidases/metabolism , Thapsigargin/pharmacology
18.
Life Sci ; 65(21): PL247-52, 1999.
Article in English | MEDLINE | ID: mdl-10576600

ABSTRACT

The effects of leucine- and methionine-enkephalin, opiate peptides, on Ca2+ efflux from cultured bovine adrenal chromaffin cells were examined. These enkephalins stimulated the efflux of 45Ca2+ from cells in a concentration-dependent manner (10(-8) M-10(-6) M). Leucine-enkephalin did not increase the intracellular free Ca2+ level, 45Ca2+ uptake, catecholamine secretion, cAMP level or cGMP level. The peptide-stimulated 45Ca2+ efflux was not inhibited by incubation in Ca2+-free medium, but was inhibited by incubation in Na+-free medium. These results indicate that enkephalins stimulate extracellular Na+-dependent 45Ca2+ efflux from cultured bovine adrenal chromaffin cells, probably by stimulating membrane Na+/Ca2+ exchange.


Subject(s)
Adrenal Medulla/cytology , Calcium/metabolism , Chromaffin Cells/metabolism , Enkephalins/pharmacology , Animals , Calcium Radioisotopes , Catecholamines/metabolism , Cattle , Cells, Cultured , Chromaffin Cells/drug effects , Cyclic AMP/metabolism , Cyclic GMP/metabolism , Enkephalin, Leucine/pharmacology , Enkephalin, Methionine/pharmacology , Fluorescent Dyes , Fura-2
19.
Yakugaku Zasshi ; 119(10): 773-9, 1999 Oct.
Article in Japanese | MEDLINE | ID: mdl-10518461

ABSTRACT

Generic drugs are widely used with the object of cost saving in many Japanese therapeutic scenes now. The products containing the same active ingredient(s), even if they are innovative drugs or generic ones, must be designed to possess the equivalent quality. In this report, we observed the dissolution behavior patterns of three generic drugs that contain Tegafur and Uracil, drugs A, B, and C, and compared them with that of an innovative product, UFT. Drugs B and C were similar to UFT in the dissolution rate of Tegafur, but drug A was not. On the dissolution rate of Uracil, all the generic products, drugs A, B and C, did not amount to the level equivalent to that of UFT. Therefore, these generic products did not indicate the same dissolution behavior pattern as UFT. It was suggested that the pharmaceutical technology used in the manufacture was not equivalent even if the products of the same dosage form contain the same kind and content of the active ingredient(s).


Subject(s)
Tegafur/chemistry , Uracil/chemistry , Capsules , Drug Combinations , Drugs, Generic , Solubility
20.
Free Radic Biol Med ; 27(3-4): 347-55, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10468208

ABSTRACT

The objective of this study was to elucidate the nitric oxide-forming reactions of the iron-N-methyl-D-glucamine dithiocarbamate (Fe-MGD) complex from the nitrogen-containing compound hydroxyurea. The Fe2+(MGD)2 complex is commonly used in electron paramagnetic resonance (EPR) spectroscopic detection of NO both in vivo and in vitro. The reaction of Fe2+(MGD)2 with NO yields the resultant NO-Fe2+(DETC)2 complex, which has a characteristic triplet EPR signal. It is widely believed that only NO reacts with Fe2+(MGD)2 to form the NO-Fe2+(MGD)2 complex. In this report, the mechanism leading to the formation of NO-Fe2+(MGD)2 was investigated using oxygen-uptake studies in conjunction with the EPR spin-trapping technique. We found that the air oxidation of Fe2+(MGD)2 complex results in the formation of the Fe3+(MGD)3 complex, presumably concomitantly with superoxide (O3*-). Dismutation of superoxide forms hydrogen peroxide, which can subsequently reduce Fe3+(MGD)3 back to Fe2+(MGD)2. The addition of NO to the Fe3+(MGD)3 complex resulted in the formation of the NO-Fe2+(MGD)2 complex. Hydroxyurea is not considered to be a spontaneous NO donor, but has to be oxidized in order to form NO. We present data showing that in the presence of oxygen, Fe2+(MGD)2 can oxidize hydroxyurea to yield the stable NO-Fe2+(MGD)2 complex. These results imply that hydroxyurea can be oxidized by reactive oxygen species that are formed from the air oxidation of the Fe2+(MGD)2 complex. Formation of the NO-Fe2+(MGD)2 complex in this case could erroneously be interpreted as spontaneous formation of NO from hydroxyurea. The chemistry of the Fe2+(MGD)2 complexes in aerobic conditions must be taken into account in order to avoid erroneous conclusions. In addition, the use of these complexes may contribute to the overall oxidative stress of the system under investigation.


Subject(s)
Ferrous Compounds/chemistry , Nitric Oxide/biosynthesis , Sorbitol/analogs & derivatives , Thiocarbamates , Water/chemistry , Chelating Agents , Cyclic N-Oxides , Electrodes , Electron Spin Resonance Spectroscopy , Ferric Compounds/chemistry , Free Radicals , Hydrogen Peroxide , Hydroxyurea/chemistry , Oxygen Consumption , Solubility , Spectrophotometry , Spin Labels , Spin Trapping
SELECTION OF CITATIONS
SEARCH DETAIL
...